Targeting M2 Macrophages with a Novel NADPH Oxidase Inhibitor
ROS in cancer cells play a key role in pathways regulating cell death, stemness maintenance, and metabolic reprogramming, all of which have been implicated in resistance to chemo/ immunotherapy. Adjusting ROS levels to reverse the resistance of cancer cells without impairing normal cell functions is...
Saved in:
Main Authors: | Sébastien Dilly (Author), Miguel Romero (Author), Stéphanie Solier (Author), Olivier Feron (Author), Chantal Dessy (Author), Anny Slama Schwok (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting NADPH Oxidase as an Approach for Diabetic Bladder Dysfunction
by: Tammyris Helena Rebecchi Silveira, et al.
Published: (2024) -
NADPH Oxidases in Pain Processing
by: Wiebke Kallenborn-Gerhardt, et al.
Published: (2022) -
NADPH Oxidases in Aortic Aneurysms
by: Morgan Salmon
Published: (2022) -
Distinction between 2'- and 3'-Phosphate Isomers of a Fluorescent NADPH Analogue Led to Strong Inhibition of Cancer Cells Migration
by: Raoul Manuel, et al.
Published: (2021) -
Role of NADPH Oxidases in Stroke Recovery
by: Dong-Hee Choi, et al.
Published: (2024)